Literature DB >> 10706504

GM-CSF and GM-CSF beta c receptor in adult patients with pulmonary alveolar proteinosis.

B Bewig1, X D Wang, D Kirsten, K Dalhoff, H Schäfer.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disorder of unknown origin characterized by alveolar fillings with periodic acid-Schiff (PAS)-positive material mainly consisting of phospholipids. Mice defective in the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene or the GM-CSF/interleukin (IL)-3/IL-5-receptor common beta chain (beta c) demonstrate a pathology resembling PAP. A recent study revealed defects in the beta c chain of the GM-CSF receptor in four out of eight paediatric patients. This study investigates the role of the GM-CSF coding region and components of the GM-CSF receptor in adult patients. Four adult patients with proven PAP were analysed for GM-CSF and GM-CSF-beta c receptor in regard to protein level, messenger ribonucleic acid (mRNA) expression and sequence composition. None of the adult patients displayed the mutation at position 1,835 of the beta c-receptor previously described in paediatric patients. Expression of the beta c receptor was found to be normal on the surface of peripheral blood cells. In three out of four patients GM-CSF release from blood cells failed to respond adequately to lipopolysaccharide (LPS). In one of these patients a heterozygous mutation was found in the GM-CSF complementary deoxyribonucleic acid (cDNA) from thymine (T) to cytosine (C) at position 382 of the published sequence putatively causing a change in the protein from isoleucine to threonine at position 117. This study indicates that the mutation of the beta chain receptors found in some of the paediatric patients suffering from pulmonary alveolar proteinosis is not a common problem in adult patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706504     DOI: 10.1034/j.1399-3003.2000.15b22.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.

Authors:  P Latzin; M Tredano; Y Wüst; J de Blic; T Nicolai; B Bewig; F Stanzel; D Köhler; M Bahuau; M Griese
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  ABCG1 regulates pulmonary surfactant metabolism in mice and men.

Authors:  Thomas Q de Aguiar Vallim; Elinor Lee; David J Merriott; Christopher N Goulbourne; Joan Cheng; Angela Cheng; Ayelet Gonen; Ryan M Allen; Elisa N D Palladino; David A Ford; Tisha Wang; Ángel Baldán; Elizabeth J Tarling
Journal:  J Lipid Res       Date:  2017-03-06       Impact factor: 5.922

3.  Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann-Pick A disease.

Authors:  R Buccoliero; L Ginzburg; A H Futerman
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.

Authors:  Takuro Sakagami; David Beck; Kanji Uchida; Takuji Suzuki; Brenna C Carey; Koh Nakata; Gary Keller; Robert E Wood; Susan E Wert; Machiko Ikegami; Jeffrey A Whitsett; Maurizio Luisetti; Stella Davies; Jeffrey P Krischer; Alan Brody; Fred Ryckman; Bruce C Trapnell
Journal:  Am J Respir Crit Care Med       Date:  2010-03-11       Impact factor: 21.405

5.  Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.

Authors:  F-C Lin; G-D Chang; M-S Chern; Y-C Chen; S-C Chang
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

6.  Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.

Authors:  Masayuki Ito; Kazuyuki Nakagome; Hiromitsu Ohta; Keiichi Akasaka; Yoshitaka Uchida; Atsushi Hashimoto; Ayako Shiono; Toshinori Takada; Makoto Nagata; Jun Tohyama; Koichi Hagiwara; Minoru Kanazawa; Koh Nakata; Ryushi Tazawa
Journal:  BMC Pulm Med       Date:  2017-02-17       Impact factor: 3.317

7.  Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

Authors:  Takuji Suzuki; Takuro Sakagami; Bruce K Rubin; Lawrence M Nogee; Robert E Wood; Sarah L Zimmerman; Teresa Smolarek; Megan K Dishop; Susan E Wert; Jeffrey A Whitsett; Gregory Grabowski; Brenna C Carey; Carrie Stevens; Johannes C M van der Loo; Bruce C Trapnell
Journal:  J Exp Med       Date:  2008-10-27       Impact factor: 14.307

8.  Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.

Authors:  Keiichi Akasaka; Takahiro Tanaka; Nobutaka Kitamura; Shinya Ohkouchi; Ryushi Tazawa; Toshinori Takada; Toshio Ichiwata; Etsuro Yamaguchi; Masaki Hirose; Toru Arai; Kentaro Nakano; Takahito Nei; Haruyuki Ishii; Tomohiro Handa; Yoshikazu Inoue; Koh Nakata
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.